Skip to Main Content

Paper Details

Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical Trials.
Inflamm Bowel Dis
6
2023
IBD, Men, Participant, TNFi, Tumor Necrosis Factor, UC, Ulcerative Colitis, golimumab, inflammatory bowel diseases, infliximab, men, participant, patient, patients, tumor, tumor necrosis factor, ulcerative colitis, women
Author NameAffiliation
Francesca PetraliaIcahn School of Medicine at Mount Sinai
Francesca PetraliaIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
Jean-Frederic ColombelIcahn School of Medicine at Mount Sinai
Shailja C ShahVA San Diego Healthcare System
Shailja C ShahUniversity of California
  • 1 - 5

Datasets

Release 1.2